| Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy (NCT07449507) | Ruijin Hospital | 2027-01-01 |
| Dietary Restriction Efficiency Assessment in CMPA (NCT07199023) | Ruijin Hospital | 2026-09-01 |
| Transcranial Temporal Interference Stimulation (tTIS) for Chronic Insomnia (NCT07755852) | Ruijin Hospital | 2026-08-30 |
| A Prospective Study of Response-adapted Low-dose Radiotherapy Combined With Orelabrutinib for Localized Mucosa-associated Lymphoid Tissue Extranodal Marginal Zone Lymphoma (NCT07705308) | Ruijin Hospital | 2026-08-01 |
| CCTA-Based vs CAG-Based CABG: A Multicenter Pragmatic Non-Inferiority Trial (NCT07769008) | Ruijin Hospital | 2026-08-01 |
| Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML (NCT07735117) | Ruijin Hospital | 2026-07-30 |
| The Safety and PK Study of Inhaled ICF004 in Healthy Chinese Volunteers (NCT07719218) | Ruijin Hospital | 2026-07-30 |
| Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer (NCT07745790) | Ruijin Hospital | 2026-07-13 |
| The Longitudinal Cohort of Cerebral Small Vessel Disease in Ruijin Hospital (NCT07726654) | Ruijin Hospital | 2026-07-08 |
| Temporal Interference Noninvasive Deep Brain Stimulation for Idiopathic Parkinson's Disease and Parkinsonian Syndromes: Effects and Target Exploration (NCT07698236) | Ruijin Hospital | 2026-07-03 |
| Artificial Intelligence-Assisted Training for Novice Physicians in Electronic Nasopharyngolaryngoscopy (NCT07726641) | Ruijin Hospital | 2026-07-01 |
| A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy (NCT07628738) | Ruijin Hospital | 2026-07-01 |
| Directional PSA Versus STN DBS for TD-PD (NCT07700862) | Ruijin Hospital | 2026-07-01 |
| CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation (NCT07672964) | Ruijin Hospital | 2026-07-01 |
| A Multicenter, Prospective, Open-Label, Randomized Controlled Clinical Study of Orelabrutinib Combined With Obinutuzumab and Lenalidomide Versus Obinutuzumab Plus Chemotherapy for Treatment-Naive Follicular Lymphoma (NCT07719855) | Ruijin Hospital | 2026-07-01 |
| Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study (NCT07664787) | Ruijin Hospital | 2026-07-01 |
| MSC-Exosome Therapy for Frontotemporal Dementia (NCT07638813) | Ruijin Hospital | 2026-07-01 |
| AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL (NCT07717177) | Ruijin Hospital | 2026-06-30 |
| Electrical Impedance Tomography-Guided Identification of the Optimal Lateral Position in Postoperative ARDS (NCT07669558) | Ruijin Hospital | 2026-06-28 |
| Pola-R-CHP Plus Sonrotoclax in Untreated BCL2-High/Double-Hit LBCL (NCT07638787) | Ruijin Hospital | 2026-06-15 |
| A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma. (NCT07657572) | Ruijin Hospital | 2026-06-01 |
| CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation (NCT07662369) | Ruijin Hospital | 2026-06-01 |
| Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling (NCT07641257) | Ruijin Hospital | 2026-05-30 |
| Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDS (NCT07607418) | Ruijin Hospital | 2026-05-22 |
| A Study of Dose Escalation of ES502 in Patients With Advanced Pancreatic Cancer (NCT07649928) | Ruijin Hospital | 2026-05-18 |
| AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL (NCT07594899) | Ruijin Hospital | 2026-05-06 |
| BCI With 40Hz Stimulation in Alzheimer's Disease (NCT07618481) | Ruijin Hospital | 2026-05-01 |
| Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL (NCT07613788) | Ruijin Hospital | 2026-05-01 |
| Study of SA+X in the Treatment of Newly Diagnosed AML (NCT07548710) | Ruijin Hospital | 2026-05-01 |
| Study on the Treatment of Double/Triple-hit DLBCL With Chidamide and Lisaftoclax in Combination With Pola-R-CHP (NCT07552324) | Ruijin Hospital | 2026-05-01 |
| Safety and Efficacy of Vertebral Body-Sparing Craniospinal Irradiation With Proton Therapy in Pediatric Tumors (NCT07589361) | Ruijin Hospital | 2026-04-30 |
| SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis (NCT07384234) | Ruijin Hospital | 2026-04-24 |
| Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer (NCT07527689) | Ruijin Hospital | 2026-04-22 |
| Effects of Glucocorticoid Therapy on Renal Function in Patients With PA Complicated by CKD After Adrenalectomy: A Multicenter RCT (NCT07558811) | Ruijin Hospital | 2026-04-22 |
| Neoadjuvant Tislelizumab + LM-302 + S-1 or Tislelizumab + SOX for CLDN18.2-Positive Gastric/GEJ Adenocarcinoma (NCT07569068) | Ruijin Hospital | 2026-04-21 |
| The Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined With Obinutuzumab in MCL (NCT07548255) | Ruijin Hospital | 2026-04-20 |
| Evaluation of GI001 for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT07584850) | Ruijin Hospital | 2026-04-20 |
| LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study (NCT07556640) | Ruijin Hospital | 2026-04-17 |
| Verification of Range Accuracy and Correlation With Clinical Toxicity Using Offline PET/CT for Hypofractionated Proton Radiotherapy in Breast Cancer (NCT07543107) | Ruijin Hospital | 2026-04-16 |
| Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging (NCT07554742) | Ruijin Hospital | 2026-04-15 |
| Proton vs Photon IMRT Toxicity in Breast Cancer (NCT07537712) | Ruijin Hospital | 2026-04-01 |
| Safety and Efficacy of Intrathecal NTF001 Injection in ALS (NCT07618585) | Ruijin Hospital | 2026-04-01 |
| KSD-101 in Patients With EBV-associated Hematological Malignancies (NCT07525024) | Ruijin Hospital | 2026-04-01 |
| The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL (NCT07514169) | Ruijin Hospital | 2026-03-31 |
| A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping (NCT07511114) | Ruijin Hospital | 2026-03-31 |
| Study on the Correlation Between Plasma Orexin Levels During the Recovery Period and Emergence Delirium in Elderly Patients (NCT07726875) | Ruijin Hospital | 2026-03-31 |
| Genotype-guided Targeted Agents Plus EZH2i for Primary Refractory PTCL (NCT07493330) | Ruijin Hospital | 2026-03-23 |
| Predictive Validity and Clinical Utility of an Ultrasound-based Quantitative Risk Score for Pressure Injury in Critically Ill Patients (NCT07496411) | Ruijin Hospital | 2026-03-20 |
| Non-apnea Electrical Impedance Tomography for Bedside Ventilation-Perfusion Assessment: a Prospective Cross-over Validation Study (NCT07489950) | Ruijin Hospital | 2026-03-19 |
| AI-Driven Autonomous Registration in Robotic Bronchoscopy (NCT07368829) | Ruijin Hospital | 2026-03-01 |
| Prospective Management of Plaque Instability With Statins and Extra Folic Acid (NCT07680595) | Ruijin Hospital | 2026-03-01 |
| Glofitamab Combined With CAR-T Therapy in R/R DLBCL (NCT07326371) | Ruijin Hospital | 2026-03-01 |
| Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT (NCT07450963) | Ruijin Hospital | 2026-03-01 |
| Multi-Omics Integrative Analysis of Serum and Sputum to Uncover Key Determinants of Prognosis in Patients With ARDS (NCT07380997) | Ruijin Hospital | 2026-03-01 |
| PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL (NCT07380984) | Ruijin Hospital | 2026-03-01 |
| Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT (NCT07511127) | Ruijin Hospital | 2026-02-28 |
| Zillion: Zanubrutinib Combined With Chemotherapy for Newly Diagnosed CNS Lymphoma (NCT07405255) | Ruijin Hospital | 2026-01-30 |
| Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients (NCT07521111) | Ruijin Hospital | 2026-01-25 |
| Clinical Study of XP-006 mRNA Vaccine for R/R B-NHL (NCT07334574) | Ruijin Hospital | 2026-01-15 |
| Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters (NCT07531446) | Ruijin Hospital | 2026-01-13 |
| Retrograde Ascending Dissection: Intraluminal Aortic Therapy (NCT07405242) | Ruijin Hospital | 2026-01-01 |
| Phase Ib/II Study to Evaluate the Safety and Efficacy of IBI363 in Combination With Chemotherapy as Second-Line Therapy for Unresectable Locally Advanced or Metastatic Pancreatic Cancer (NCT07342725) | Ruijin Hospital | 2026-01-01 |
| The Effect of Spinal Cord Stimulation on Orthostatic Hypotension in Parkinsonism and Its Related Mechanisms (NCT07322458) | Ruijin Hospital | 2026-01-01 |
| A Study of Cizutamig for Patients With Ulcerative Colitis (NCT07353450) | Ruijin Hospital | 2026-01-01 |
| QL1706 Plus Chemotherapy for Borderline Resectable Esophageal Cancer (NCT07283991) | Ruijin Hospital | 2025-12-30 |
| Pilot Trial of Colchicine for Graft Failure in CABG (NCT06802926) | Ruijin Hospital | 2025-12-29 |
| Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases (NCT07322718) | Ruijin Hospital | 2025-12-24 |
| Golidocitinib Combined With GemOx in RR PTCL (NCT07279584) | Ruijin Hospital | 2025-12-20 |
| Shanghai Lymphoma Clinical Cohort (NCT07285174) | Ruijin Hospital | 2025-12-18 |
| IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy (NCT07306273) | Ruijin Hospital | 2025-12-15 |
| BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients (NCT07301138) | Ruijin Hospital | 2025-12-15 |
| Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy (NCT07306286) | Ruijin Hospital | 2025-12-15 |
| AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study (NCT07326358) | Ruijin Hospital | 2025-12-12 |
| Evaluation of the Efficacy and Safety of Palmitoleic Acid Oil Composition in Preventing Pressure Injuries (NCT07547254) | Ruijin Hospital | 2025-12-01 |
| Safety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass Nodules (NCT07232433) | Ruijin Hospital | 2025-11-21 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A. (NCT07229547) | Ruijin Hospital | 2025-11-14 |
| A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19 (NCT07269587) | Ruijin Hospital | 2025-11-07 |
| Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's Disease (NCT07543094) | Ruijin Hospital | 2025-11-01 |
| Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease (NCT07157345) | Ruijin Hospital | 2025-10-20 |
| Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy (NCT07197112) | Ruijin Hospital | 2025-10-01 |
| Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation (NCT07498855) | Ruijin Hospital | 2025-10-01 |
| Combination Therapy With Tazemetostat in Relapsed and Refractory Peripheral T-cell Lymphoma (NCT07209163) | Ruijin Hospital | 2025-10-01 |
| A Study of Firsekibart Versus Anakinra in Adult-Onset Still's Disease (NCT07191444) | Ruijin Hospital | 2025-09-24 |
| A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA） (NCT07191431) | Ruijin Hospital | 2025-09-22 |
| Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease (NCT07272499) | Ruijin Hospital | 2025-09-10 |
| SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC (NCT07198165) | Ruijin Hospital | 2025-09-05 |
| A Study of Cizutamig in Systemic Sclerosis (NCT07158996) | Ruijin Hospital | 2025-09-04 |
| A Study of GB261 in Systemic Sclerosis (NCT07159009) | Ruijin Hospital | 2025-09-04 |
| (68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis (NCT07151521) | Ruijin Hospital | 2025-09-01 |
| Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia (NCT07087847) | Ruijin Hospital | 2025-09-01 |
| Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis (NCT07131150) | Ruijin Hospital | 2025-08-31 |
| Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease (NCT07151157) | Ruijin Hospital | 2025-08-30 |
| Sedation and Analgesia Bundled Strategies Among ICU Nurses (NCT07132450) | Ruijin Hospital | 2025-08-30 |
| HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer (NCT07131514) | Ruijin Hospital | 2025-08-25 |
| SEEG-Guided DBS for Schizophrenia (NCT07671261) | Ruijin Hospital | 2025-08-17 |
| Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD. (NCT07184697) | Ruijin Hospital | 2025-08-14 |
| Pirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT07122609) | Ruijin Hospital | 2025-08-05 |
| The Efficacy and Safety of Puerarin in Obesity Treatment (NCT06968208) | Ruijin Hospital | 2025-08-01 |
| Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML (NCT07091006) | Ruijin Hospital | 2025-08-01 |
| A Clinical Study of the Safety and Efficacy of Chemogenetics Therapy in the Treatment of Parkinson's Disease (NCT07085195) | Ruijin Hospital | 2025-08-01 |